WeVote
Log In

Bill

Bill

HB 1826

Modifies provisions relating to epinephrine delivery systems

2026 Regular Session Introduced by Anthony Ealy and 6 co-sponsors

HB 1826 modifies epinephrine auto-injector delivery regulations in Missouri to improve emergency access and administration protocols for anaphylaxis treatment.

Placed on Informal Calendar
#healthcare #healthcareprofessionals #health #public #childrenandminors #drugsandcontrolledsubstances #emergencies #healthandseniorservices #departmentof
0
WeVote Research Nonpartisan
Bill Summary · HB 1826

Legislative bill overview

HB 1826 modifies Missouri's provisions governing epinephrine delivery systems, likely addressing auto-injector accessibility, administration protocols, or regulatory requirements for emergency epinephrine use. The bill received unanimous committee support (17-0) and has advanced through the House Health and Mental Health Committee.

Why is this important

Epinephrine auto-injectors (like EpiPens) are critical emergency medications for anaphylaxis, a potentially fatal allergic reaction. Changes to delivery systems, accessibility standards, or administration protocols can affect whether patients, schools, workplaces, and emergency responders can quickly access life-saving treatment during severe allergic reactions.

Potential points of contention

  • Cost and access barriers: Modifications that affect insurance coverage, generic alternatives, or public stockpiling requirements could impact affordability for low-income patients
  • Liability and administration authority: Expanding who can administer epinephrine (laypersons, school staff, untrained bystanders) raises questions about liability protection and training standards
  • Pharmaceutical industry influence: Changes to epinephrine delivery specifications could favor certain manufacturers or affect generic competition in the market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.